Literature DB >> 19460681

Management of chronic rhinosinusitis in CF.

Jochen G Mainz1, Assen Koitschev.   

Abstract

Routine CF management often does not include upper airway (UAW) assessment although CFTR defects equally affect the sinonasal mucosa. Up to 50% of CF patients have chronic rhinosinusitis (CRS) and/or nasal polyps, and almost 100% reveal UAW abnormalities on CT scan. CRS impairs quality of life. UAW dysfunction in filtering, humidifying, and warming inspired air affects lower airways and the UAW is a potential site of first colonization and a reservoir for opportunistic bacteria. Therefore, UAW pathology substantially affects overall health in CF. Standard treatments are scarce and mostly lack evidence. Nasal douche can remove mucus and crusts. Recently, delivery of dornase alfa using a vibrating aerosol has shown potential as treatment for CF-related CRS. Surgery is indicated when conservative approaches fail but postoperative relapse is frequent. In summary, upper airway involvement in CF is undertreated and requires prospective investigation and an interdisciplinary consensus on diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460681     DOI: 10.1016/S1569-1993(09)60005-9

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  16 in total

Review 1.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

2.  Smell in cystic fibrosis.

Authors:  J Lindig; C Steger; N Beiersdorf; R Michl; J F Beck; T Hummel; J G Mainz
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-14       Impact factor: 2.503

3.  Sinonasal characteristics and quality of life by SNOT-22 in adult patients with cystic fibrosis.

Authors:  Suzie Hyeona Kang; Camila Degen Meotti; Karine Bombardelli; Otávio Bejzman Piltcher; Paulo de Tarso Roth Dalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-18       Impact factor: 2.503

Review 4.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 5.  Cigarette smoke and CFTR: implications in the pathogenesis of COPD.

Authors:  Andras Rab; Steven M Rowe; S Vamsee Raju; Zsuzsa Bebok; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-09       Impact factor: 5.464

6.  T2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patients.

Authors:  Nithin D Adappa; Alan D Workman; Denis Hadjiliadis; Daniel J Dorgan; Danielle Frame; Steven Brooks; Laurel Doghramji; James N Palmer; Corrine Mansfield; Danielle R Reed; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-17       Impact factor: 3.858

7.  Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.

Authors:  Kiranya E Tipirneni; Bradford A Woodworth
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-02-21

Review 8.  [Rhinosinusitis in cystic fibrosis].

Authors:  J G Mainz; A Gerber; C Arnold; J Baumann; I Baumann; A Koitschev
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

9.  Defective fluid secretion from submucosal glands of nasal turbinates from CFTR-/- and CFTR (ΔF508/ΔF508) pigs.

Authors:  Hyung-Ju Cho; Nam Soo Joo; Jeffrey J Wine
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

10.  Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Authors:  Jochen G Mainz; Andrea Gerber; Michael Lorenz; Ruth Michl; Julia Hentschel; Anika Nader; James F Beck; Mathias W Pletz; Andreas H Mueller
Journal:  Case Rep Infect Dis       Date:  2015-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.